191 related articles for article (PubMed ID: 25979827)
1. Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2.
Dann SG; Ryskin M; Barsotti AM; Golas J; Shi C; Miranda M; Hosselet C; Lemon L; Lucas J; Karnoub M; Wang F; Myers JS; Garza SJ; Follettie MT; Geles KG; Klippel A; Rollins RA; Fantin VR
EMBO J; 2015 Jul; 34(13):1773-85. PubMed ID: 25979827
[TBL] [Abstract][Full Text] [Related]
2. The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.
Zingg D; Debbache J; Schaefer SM; Tuncer E; Frommel SC; Cheng P; Arenas-Ramirez N; Haeusel J; Zhang Y; Bonalli M; McCabe MT; Creasy CL; Levesque MP; Boyman O; Santoro R; Shakhova O; Dummer R; Sommer L
Nat Commun; 2015 Jan; 6():6051. PubMed ID: 25609585
[TBL] [Abstract][Full Text] [Related]
3. A druggable cascade links methionine metabolism to epigenomic reprogramming in squamous cell carcinoma.
Nam C; Li LY; Yang Q; Ziman B; Zhao H; Hu B; Collet C; Jing P; Lei Q; Xu LY; Li EM; Koeffler HP; Sinha UK; Lin DC
Proc Natl Acad Sci U S A; 2024 Jun; 121(26):e2320835121. PubMed ID: 38900797
[TBL] [Abstract][Full Text] [Related]
4. The polycomb group protein EZH2 inhibits lung cancer cell growth by repressing the transcription factor Nrf2.
Li Z; Xu L; Tang N; Xu Y; Ye X; Shen S; Niu X; Lu S; Chen Z
FEBS Lett; 2014 Aug; 588(17):3000-7. PubMed ID: 24928441
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
6. EZH2 is essential for glioblastoma cancer stem cell maintenance.
Suvà ML; Riggi N; Janiszewska M; Radovanovic I; Provero P; Stehle JC; Baumer K; Le Bitoux MA; Marino D; Cironi L; Marquez VE; Clément V; Stamenkovic I
Cancer Res; 2009 Dec; 69(24):9211-8. PubMed ID: 19934320
[TBL] [Abstract][Full Text] [Related]
7. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide transcriptional profiling analysis reveals annexin A6 as a novel EZH2 target gene involving gastric cellular proliferation.
Qi Y; Zhang X; Kang Y; Wu J; Chen J; Li H; Guo Y; Liu B; Shao Z; Zhao X
Mol Biosyst; 2015 Jul; 11(7):1980-6. PubMed ID: 25947258
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
10. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
11. EZH2 promotes a bi-lineage identity in basal-like breast cancer cells.
Granit RZ; Gabai Y; Hadar T; Karamansha Y; Liberman L; Waldhorn I; Gat-Viks I; Regev A; Maly B; Darash-Yahana M; Peretz T; Ben-Porath I
Oncogene; 2013 Aug; 32(33):3886-95. PubMed ID: 22986524
[TBL] [Abstract][Full Text] [Related]
12. EZH2 as a potential target in cancer therapy.
McCabe MT; Creasy CL
Epigenomics; 2014 Jun; 6(3):341-51. PubMed ID: 25111487
[TBL] [Abstract][Full Text] [Related]
13. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
[TBL] [Abstract][Full Text] [Related]
14. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.
Hemming S; Cakouros D; Isenmann S; Cooper L; Menicanin D; Zannettino A; Gronthos S
Stem Cells; 2014 Mar; 32(3):802-15. PubMed ID: 24123378
[TBL] [Abstract][Full Text] [Related]
15. Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy.
Ohkawa M; Ohno Y; Masuko K; Takeuchi A; Suda K; Kubo A; Kawahara R; Okazaki S; Tanaka T; Saya H; Seki M; Enomoto T; Yagi H; Hashimoto Y; Masuko T
Biochem Biophys Res Commun; 2011 Mar; 406(4):649-55. PubMed ID: 21371427
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modification in gliomas: role of the histone methyltransferase EZH2.
Bian EB; Li J; He XJ; Zong G; Jiang T; Li J; Zhao B
Expert Opin Ther Targets; 2014 Oct; 18(10):1197-206. PubMed ID: 25046371
[TBL] [Abstract][Full Text] [Related]
17. FOXA1 antagonizes EZH2-mediated CDKN2A repression in carcinogenesis.
Zhang Y; Tong T
Biochem Biophys Res Commun; 2014 Oct; 453(1):172-8. PubMed ID: 25264199
[TBL] [Abstract][Full Text] [Related]
18. EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21(waf1/cip1) and by inhibiting mutant p53.
Seward S; Semaan A; Qazi AM; Gruzdyn OV; Chamala S; Bryant CC; Kumar S; Cameron D; Sethi S; Ali-Fehmi R; Morris R; Bouwman DL; Munkarah AR; Weaver DW; Gruber SA; Batchu RB
Cancer Lett; 2013 Aug; 336(1):53-60. PubMed ID: 23603558
[TBL] [Abstract][Full Text] [Related]
19. c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells.
Hayashi K; Jutabha P; Endou H; Anzai N
Oncol Rep; 2012 Sep; 28(3):862-6. PubMed ID: 22736142
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of enhancer of zests homolog 2 in lymphoma.
Guo SQ; Zhang YZ
Chin Med J (Engl); 2012 Oct; 125(20):3735-9. PubMed ID: 23075734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
